Ken Fisher’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-198,287
| Closed | -$10.8M | – | 1041 |
|
|
2025
Q3 | $10.8M | Buy |
198,287
+40,258
| +25% | +$2.01M | ﹤0.01% | 397 |
|
|
2025
Q2 | $8.4M | Sell |
158,029
-27,925
| -15% | -$1.42M | ﹤0.01% | 423 |
|
|
2025
Q1 | $8.05M | Buy |
185,954
+9,317
| +5% | +$472K | ﹤0.01% | 438 |
|
|
2024
Q4 | $9.93M | Buy |
176,637
+53,735
| +44% | +$3.34M | ﹤0.01% | 433 |
|
|
2024
Q3 | $8.37M | Sell |
122,902
-36,302
| -23% | -$2.05M | ﹤0.01% | 440 |
|
|
2024
Q2 | $6.73M | Buy |
159,204
+1,447
| +0.9% | +$79.6K | ﹤0.01% | 464 |
|
|
2024
Q1 | $10.9M | Buy |
157,757
+5,398
| +4% | +$341K | 0.01% | 415 |
|
|
2023
Q4 | $11.3M | Sell |
152,359
-2,010
| -1% | -$132K | 0.01% | 394 |
|
|
2023
Q3 | $10.5M | Buy |
154,369
+42,305
| +38% | +$3.59M | 0.01% | 433 |
|
|
2023
Q2 | $10.5M | Sell |
112,064
-511
| -0.5% | -$39.9K | 0.01% | 446 |
|
|
2023
Q1 | $7.63M | Sell |
112,575
-46,318
| -29% | -$2.98M | ﹤0.01% | 488 |
|
|
2022
Q4 | $7.87M | Buy |
158,893
+35,542
| +29% | +$1.45M | 0.01% | 476 |
|
|
2022
Q3 | $4.01M | Buy |
123,351
+12,596
| +11% | +$519K | ﹤0.01% | 484 |
|
|
2022
Q2 | $4.36M | Buy |
110,755
+69,367
| +168% | +$3.71M | ﹤0.01% | 438 |
|
|
2022
Q1 | $2.89M | Buy |
41,388
+508
| +1% | +$37.1K | ﹤0.01% | 509 |
|
|
2021
Q4 | $3.18M | Buy |
40,880
+15,511
| +61% | +$1.37M | ﹤0.01% | 506 |
|
|
2021
Q3 | $2.42M | Sell |
25,369
-2,747
| -10% | -$290K | ﹤0.01% | 508 |
|
|
2021
Q2 | $3.5M | Buy |
28,116
+2,163
| +8% | +$258K | ﹤0.01% | 464 |
|
|
2021
Q1 | $3.42M | Buy |
25,953
+4,579
| +21% | +$627K | ﹤0.01% | 466 |
|
|
2020
Q4 | $2.83M | Buy |
21,374
+4,972
| +30% | +$601K | ﹤0.01% | 474 |
|
|
2020
Q3 | $1.67M | Buy |
16,402
+387
| +2% | +$33.4K | ﹤0.01% | 507 |
|
|
2020
Q2 | $1.39M | Sell |
16,015
-318
| -2% | -$25.4K | ﹤0.01% | 530 |
|
|
2020
Q1 | $947K | Sell |
16,333
-7,722
| -32% | -$627K | ﹤0.01% | 541 |
|
|
2019
Q4 | $2.23M | Sell |
24,055
-41,985
| -64% | -$3.69M | ﹤0.01% | 480 |
|
|
2019
Q3 | $5.97M | Sell |
66,040
-2,110
| -3% | -$240K | 0.01% | 424 |
|
|
2019
Q2 | $8.04M | Buy |
68,150
+16,771
| +33% | +$1.69M | 0.01% | 384 |
|
|
2019
Q1 | $4.45M | Sell |
51,379
-4,272
| -8% | -$364K | 0.01% | 426 |
|
|
2018
Q4 | $3.51M | Sell |
55,651
-400
| -0.7% | -$27.5K | ﹤0.01% | 457 |
|
|
2018
Q3 | $4.42M | Buy |
56,051
+430
| +0.8% | +$28K | 0.01% | 436 |
|
|
2018
Q2 | $3.33M | Buy |
+55,621
| New | +$2.99M | ﹤0.01% | 484 |
|
|
2018
Q1 | – | Sell |
-6,350
| Closed | -$334K | – | 784 |
|
|
2017
Q4 | $334K | Hold |
6,350
| – | – | ﹤0.01% | 713 |
|
|
2017
Q3 | $299K | Buy |
+6,350
| New | +$256K | ﹤0.01% | 685 |
|
Other funds holding EXAS
HI
PCM
FCM
DKCM
Ken Fisher's EXAS Position: Q4 2025 in Review
Ken Fisher sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 198,287 shares — an estimated $10.8M sold.
Ken Fisher first reported a position in EXAS in Q3 2017 and held it in 32 quarters. The position peaked at $11.3M in Q4 2023. 710 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.
- Ken Fisher reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
- Ken Fisher sold 198,287 Exact Sciences shares in Q4 2025, an estimated $10.8M.
- Ken Fisher first reported a position in Exact Sciences in Q3 2017 and held it in 32 quarters.
- Ken Fisher's Exact Sciences position peaked at $11.3M in Q4 2023.
- 710 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.
Based on Fisher Asset Management's 13F filing for Q4 2025, filed 9 Feb 2026.